Venture Life Group (LON:VLG) Trading Down 0.7% – Here’s Why

Shares of Venture Life Group plc (LON:VLG) were down 0.7% during trading on Thursday . The stock traded as low as GBX 36.60 ($0.46) and last traded at GBX 37.25 ($0.47). Approximately 58,251 shares traded hands during trading, a decline of 68% from the average daily volume of 180,257 shares. The stock had previously closed at GBX 37.50 ($0.47).

Venture Life Group Price Performance

The firm has a 50-day moving average of GBX 40.86 and a 200 day moving average of GBX 43.88. The company has a debt-to-equity ratio of 28.45, a current ratio of 2.22 and a quick ratio of 1.48. The company has a market capitalization of £47.33 million, a PE ratio of 3,700.00, a PEG ratio of 5.67 and a beta of 0.30.

Insider Buying and Selling at Venture Life Group

In other news, insider Mark Adams acquired 116,496 shares of the firm’s stock in a transaction that occurred on Wednesday, October 30th. The stock was purchased at an average cost of GBX 43 ($0.54) per share, for a total transaction of £50,093.28 ($63,225.14). 10.41% of the stock is currently owned by insiders.

About Venture Life Group

Venture Life Group plc develops and commercializes healthcare products in the United Kingdom, the Netherlands, China, Germany, Italy, Switzerland, rest of Europe, and internationally. The company offers oral healthcare products, including mouthwash, toothpaste, breath freshening capsules, and dental accessories under UltraDEX and Dentyl Dual Action brands; and proctology products, such as Procto-eze Plus range for treating the discomfort caused by haemorrhoids.